[Prospects of use of research results for drugs with anitihypoxic and antioxidative properties in neuroprotective treatment strategies (Opinion of the Council of Experts dated 26 March 2022)].

I A Voznyuk,V V Zakharov,M M Tanashyan,M V Putilina,S A Zhivolupov, O V Vorobyeva, M A Granovskaya, An B Danilov,Al B Danilov,V N Shishkova,N V Pizova,I A Litvinenko,P I Kuznetsova,A A Raskurazhev,V V Butsev

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova（2022）

引用 1|浏览4

暂无评分

摘要

Cerebrovascular diseases are one of the main causes of death and permanent disability. Effective and timely neuroprotective therapy can reduce the burden of cerebrovascular disease. The possibilities of neuroprotection as a method of prevention and medical rehabilitation of acute and chronic cerebrovascular diseases are addressed.

查看译文

关键词

asthenia,asthenic syndrome,cognitive impairment,ethylmethylhydroxypyridine succinate,ischemic stroke,meldonium,neuroactivation,neuroprotection,neurorecovery

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要